Results 41 to 50 of about 2,154,351 (306)

Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination

Circulation Research, 2022
The risk of stroke and cerebrovascular disease complicating infection with SARS-CoV-2 has been extensively reported since the onset of the pandemic. The striking efforts of many scientists in cooperation with regulators and governments worldwide have rapidly brought the development of a large landscape of vaccines against SARS-CoV-2.
Manuela De Michele, Joshua Kahan, Irene Berto, Oscar G. Schiavo, Marta Iacobucci, Danilo Toni, Alexander E. Merkler   +6 more
openaire   +3 more sources

Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

, 2022
BACKGROUND: The effectiveness of fluvoxamine to shorten symptom duration or prevent hospitalization among outpatients in the US with mild to moderate symptomatic coronavirus disease 2019 (COVID-19) is unclear. DESIGN: ACTIV-6 is an ongoing, decentralized,
Boulware, David R., Stewart, Thomas G., Adam, Stacey J., Castro, Mario, Lindsell, Christopher J., Hanna, George, Ruiz-Unger, Juan, Singh, Upinder, Gentile|, Hernandez, Adrian F., Wilder, Rhonda, Thicklin, Florence, McTigue, Kathleen, Ginde, Adit A., Bramante, Carolyn, DeLong, Allison, Felker, G. Michael, Dolor, Rowena J., McCarthy, Matthew W., Wilson, Sybil, Sulkowski, Mark, Collins, Sean, Dunsmore, Sarah E., Jayaweera, Dushyantha, Remaly, April, Gentile, Nina, Naggie, Susanna, Shenkman, Elizabeth   +27 more
core   +1 more source

Acceptability and feasibility of strategies to shield the vulnerable during the COVID-19 outbreak: a qualitative study in six Sudanese communities

BMC Public Health, 2021
Background Shielding of high-risk groups from coronavirus disease (COVID-19) has been suggested as a realistic alternative to severe movement restrictions during the COVID-19 epidemic in low-income countries. The intervention entails the establishment of
Nada Abdelmagid, Salma A. E. Ahmed, Nazik Nurelhuda, Israa Zainalabdeen, Aljaile Ahmed, Mahmoud Ali Fadlallah, Maysoon Dahab   +6 more
doaj   +1 more source

Procalcitonin as a Predictive Factor for the Clinical Outcome of Patients with Coronavirus Disease 2019 [PDF]

Journal of Acute Care Surgery, 2022
Purpose The coronavirus disease 2019 (COVID-19) pandemic continues. It has been reported that patients with bacterial coinfection have a higher mortality rate than patients without coinfection.
Sungho Lee, Jung Mo Lee, Taeyang Choi, Kwanhoon Park, Kang Yoon Lee, Ji young Jang   +5 more
doaj   +1 more source

Clinical characteristics of patients with COVID-19 admitted to the COVID-19 Emergency Field Hospital of Bangkalan, Indonesia [version 2; peer review: 2 approved]

F1000Research, 2022
Background: Following the surge of coronavirus disease 2019 (COVID-19) cases in the epicenter of East Java Province, this study aimed to determine the clinical characteristics of patients with COVID-19 at one of the emergency field hospitals in Indonesia.
Ahmad Maulana Ifan Akbas, Nathania Djaja, Perthdyatama Syifaq Budiono, Kurnia Auliyana Ar-Rahmah, Erwin Astha Triyono, Fenska Seipalla, Yussika Fernanda, Aditya Putra Pamungkas, Clarissa Azalia Maheswari, Alfin Jam'Annuri   +9 more
doaj   +1 more source

COVID-19 and Diabetes [PDF]

Journal of Clinical Medicine, 2021
Diabetes mellitus (DM) is one of the most common comorbid conditions in persons with COVID-19 and a risk factor for poor prognosis. The reasons why COVID-19 is more severe in persons with DM are currently unknown although the scarce data available on patients with DM hospitalized because of COVID-19 show that glycemic control is inadequate.
Virginia Bellido, Antonio Pérez
openaire   +4 more sources

Etoposide as Salvage Therapy for Cytokine Storm due to COVID-19

, 2020
Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality because of a lack of effective therapies. Therapeutic strategies under investigation target the overactive cytokine response with anti-cytokine or immunomodulators ...
Bromberg, Michael, Criner, Gerard J., 0000-0002-1828-6524, 0000-0003-2402-1351, Caricchio, Roberto, Patel, Maulin, Sacher, Daniel, Desai, Parag, Chandar, Ashwin, Dominguez Castillo, Eduardo, 0000-0002-1379-1118   +10 more
core   +1 more source

Preliminary predictive criteria for COVID-19 cytokine storm

, 2020
Objectives: To develop predictive criteria for COVID-19-associated cytokine storm (CS), a severe hyperimmune response that results in organ damage in some patients infected with COVID-19.
Bromberg, Michael, 0000-0003-4737-8003, Criner, Gerard J., Zhang, Xinyan, Gallucci, Marcello, Dass, Chandra, Caricchio, Roberto, Gallucci, Stefania, Fleece, David, 0000-0002-1379-1118   +9 more
core   +1 more source

Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India

Scientific Reports, 2021
COVID-19 has emerged as global pandemic with largest damage to the public health, economy and human psyche.The genome sequence data obtained during the ongoing pandemic are valuable to understand the virus evolutionary patterns and spread across the ...
Shashi Sharma, Paban Kumar Dash, Sushil Kumar Sharma, Ambuj Srivastava, Jyoti S. Kumar, B. S. Karothia, K. T. Chelvam, Sandeep Singh, Abhaydeep Gupta, Ram Govind Yadav, Ruchi Yadav, T. S. Greeshma, Pramod Kumar Kushwaha, Ravi Bhushan Kumar, D. P. Nagar, Manvendra Nandan, Subodh Kumar, Duraipandian Thavaselvam, Devendra Kumar Dubey   +18 more
doaj   +1 more source

COVID-19 Solution

International Journal of Preventive Medicine, 2020
Coronaviruses (CoV) are RNA viruses that cause endemic infections in various species of mammals and avian birds. There are seven known human CoVs, each of which causes respiratory diseases: together account for about one third of common colds. Some CoVs have recently entered humans from infected animals and lastly we have SARS COVID-19, (CoV), which ...
Roberto Menicagli, Mario Limodio
openaire   +3 more sources